Individualization of treatment strategies-Reference-Cited by-同舟云学术

Individualization of treatment strategies

Published:2011-09 Issue:S6 Volume:28 Page:19-38
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Therapy

Author:

Fernández Ortega Adela,Jolis López Laura,Viñas Villaró Gemma,Villanueva Vázquez Rafael,García Arias Alicia,González Farré Xavier,González Jiménez Sonia,Saura Manich Cristina,Cortés Castán Javier

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12325-011-0033-1.pdf

Reference74 articles.

1. Bland KI, Copeland EM. The Breast: Comprehensive Management of Benign and Malignant Diseases. Chapter 24: Clinically Established Prognostic Factors in Breast Cancer. Lea & Febiger, Philadelphia; 1991.

2. Cuadros M, Llanos A. Validation and clinical application of MammaPrint® in patients with breast cancer. Med Clin (Barc.). 2011;136:627–632.

3. Mehta R, Jain RK, Badve S. Personalized medicine: the road ahead. Clin Breast Cancer. 2011;11:20–26.

4. Byar DP, Sears ME, McGuire WL. Relationship between estrogen receptor values and clinical data in predicting the response to endocrine therapy for patients with advanced breast cancer. Eur J Cancer. 1979;15:299–310.

5. Early Breast Cancer Trialists’ Collaborative Group Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet. 1998;351:1451–1467.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exercise for improving bone health in women treated for stages I–III breast cancer: a systematic review and meta-analyses;Journal of Cancer Survivorship;2017-06-21

2. Effect of obesity on aromatase inhibitor efficacy in postmenopausal, hormone receptor-positive breast cancer: a systematic review;Breast Cancer Research and Treatment;2014-08-14

3. Evaluation of Endometrial Thickness and Bone Mineral Density Based on CYP2D6 Polymorphisms in Turkish Breast Cancer Patients Receiving Tamoxifen Treatment;Pharmacology;2014

4. Company Profile: NeoGenomics Laboratories, Inc.;Personalized Medicine;2012-11

5. Personalized Medicine and Cancer;Journal of Personalized Medicine;2012-01-30